MedPath

OBAGI COSMECEUTICALS LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

16

FDA:16

Drug Approvals

OBAGI-C RX system NORMAL-oily

Approval Date
Jan 26, 2023
FDA

NU-DERM system NORMAL-DRY

Approval Date
Jan 26, 2023
FDA

NU-DERM system NORMAL-oily

Approval Date
Jan 26, 2023
FDA

OBAGI-C RX System NORMAL-DRY

Approval Date
Jan 26, 2023
FDA

nu-derm system normal-dry

Approval Date
Jan 19, 2023
FDA

NU-DERM System NORMAL-Oily

Approval Date
Jan 19, 2023
FDA

Tretinoin

Approval Date
May 1, 2021
FDA

OBAGI-C Rx system C-CLARIFYING SERUM NORMAL TO oily

Approval Date
Jun 2, 2020
FDA

Obagi-C Rx system C-Therapy Night

Approval Date
Jun 1, 2020
FDA

OBAGI C RX system C CLARIFYING SERUM

Approval Date
Dec 24, 2019
FDA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.